Manifestaciones cardiovasculares de anemia de células falciformes
Tài liệu tham khảo
Pereira, 1996, Hemoglobinopatías en niños, Colomb Méd., 27, 146
Bunn, 1997, Pathogenesis and treatment of sickle cell disease, N Engl J Med., 337, 762, 10.1056/NEJM199709113371107
Rees, 2010, Sickle-cell disease, Lancet., 376, 2018, 10.1016/S0140-6736(10)61029-X
Gladwin, 2008, Pulmonary complications of sickle cell disease, N Engl J Med., 359, 2254, 10.1056/NEJMra0804411
Kaul, 2000, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice, J Clin Invest., 106, 411, 10.1172/JCI9225
Aisiku, 2009, Comparisons of high versus low emergency department utilizers in sickle cell disease, Ann Emerg Med., 53, 587, 10.1016/j.annemergmed.2008.07.050
Platt, 1994, Mortality in sickle cell disease. Life expectancy and risk factors for early death, N Engl J Med., 330, 1639, 10.1056/NEJM199406093302303
Steinberg, 2003, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment, JAMA., 289, 1645, 10.1001/jama.289.13.1645
Fitzhugh, 2010, Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease, Am J Hematol., 85, 36
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third Universal Definition of Myocardial Infarction. Circulation. 2012; 126: 2020-2035.
Pannu, 2008, Acute myocardial infarction in sickle cell disease. A systematic review, Crit Pathways in Cardiol., 7, 133, 10.1097/HPC.0b013e3181668ac3
Voskaridou, 2012, Sickle-cell disease and the heart: Review of the current literature, Br J Haematol., 157, 664, 10.1111/j.1365-2141.2012.09143.x
Wethers, 2000, Sickle cell disease in childhood: part II. Diagnosis and treatment of major complications and recent advances in treatment, Am Fam Phys., 62, 1309
Chun, 1970, Abnormal rheology of oxygenated blood in sickle cell anemia, J Clin Invest., 49, 623, 10.1172/JCI106273
De Chadarevian, 2001, Splenic arteries and veins in pediatric sickle cell disease, Pediatr Dev Pathol., 4, 538, 10.1007/s10024001-0045-y
Sparkenbaugh, 2013, Interplay between coagulation and vascular inflammation in sickle cell disease, Br J Haematol., 162, 3, 10.1111/bjh.12336
Jennings, 2009, Role of platelets in atherothrombosis, Am J Cardiol., 2, 4A, 10.1016/j.amjcard.2008.11.017
Hatzipantelis, 2013, Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease, Int J Hematol., 98, 158, 10.1007/s12185-013-1392-y
Bennett, 2006, Vasoocclusion in sickle cell anemia: Are platelets really involved?, Arterioscler Thromb Vasc Biol., 26, 1626, 10.1161/01.ATV.0000227595.97898.3f
Huang, 2008, Cardiovascular pathogenesis in hyperhomocysteinemia, Asia Pac J Clin Nutr., 17, 8
Lowenthal, 2000, Homocysteine elevation in sickle cell disease, J Am Coll Nutr., 19, 608, 10.1080/07315724.2000.10718958
Brattstrom, 1988, Folic acid-an innocuous means to reduce plasma homocysteine, Scand J Clin Lab Invest., 48, 215, 10.3109/00365518809167487
Tonino, 2013, Chest pain in sickle cell disease, Neth J Med., 71, 265
James, 2000, Homage to James B. Herrick: A contemporary look at myocardial infarction and at sickle-cell heart disease: The 32nd. Annual Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association, Circulation., 101, 1874, 10.1161/01.CIR.101.15.1874
Aslam, 2009, Cardiac troponin I in sickle cell crisis, Int J Cardiol., 133, 138, 10.1016/j.ijcard.2007.08.135
Vichinsky, 2000, Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group, N Engl J Med., 342, 1855, 10.1056/NEJM200006223422502
Claster, 2003, Managing sickle cell disease, BMJ., 327, 1151, 10.1136/bmj.327.7424.1151
Telen, 2001, Principles and problems of transfusion in sickle cell disease, Semin Hematol., 38, 315, 10.1016/S0037-1963(01)90025-3
Pavlu, 2007, Myocardial infarction in sickle-cell disease, Lancet., 369, 246, 10.1016/S0140-6736(07)60114-7
Wang, 2004, Acute myocardial infarction in hemoglobin SC disease, Ann Hematol., 83, 622, 10.1007/s00277-004-0907-2
Wayne, 1993, Transfusion management of sickle cell disease, Blood, 81, 1109, 10.1182/blood.V81.5.1109.bloodjournal8151109
Greenberg, 1983, Trial of low doses of aspirin as prophylaxis in sickle cell disease, J Pediatr., 102, 781, 10.1016/S0022-3476(83)80258-3
De Montalembert, 2004, Myocardial ischaemia in children with sickle cell disease, Arch Dis Child., 89, 359, 10.1136/adc.2003.027326
Potoka, 2015, Vasculopathy and pulmonary hypertension in sickle cell disease, Am J Physiol Pulm Cell Mol Physiol., 308, 314, 10.1152/ajplung.00252.2014
De Castro, 2008, Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes, Am J Hematol., 83, 19, 10.1002/ajh.21058
Ataga, 2004, Pulmonary hypertension in sickle cell disease, Am J Med., 117, 665, 10.1016/j.amjmed.2004.03.034
Nouraie, 2013, The relationship between the severity of hemolysis, clinical manifestations and risk of death in patients with sickle cell anemia in the US and Europe, Haematologica., 98, 464, 10.3324/haematol.2012.068965
Gladwin, 2005, Cardiopulmonary complications of sickle cell disease: Role of nitric oxide and hemolytic anemia, Hematology Am Soc Hematol Educ Program., 5, 1
Donadee, 2011, Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion, Circulation., 124, 465, 10.1161/CIRCULATIONAHA.110.008698
Morris, 2005, Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease, JAMA., 294, 81, 10.1001/jama.294.1.81
Ergul, 2004, Vasoactive factors in sickle cell disease: In vitro evidence for endothelin-1-mediated vasoconstriction, Am J Hematol., 76, 245, 10.1002/ajh.20107
Gladwin, 2012, Cardiovascular abnormalities in sickle cell disease, J Am Coll Cardiol., 59, 1123, 10.1016/j.jacc.2011.10.900
Kato, 2007, Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes, Blood Rev., 21, 37, 10.1016/j.blre.2006.07.001
Mekontso, 2008, Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease, Am J Respir Crit Care Med., 177, 646, 10.1164/rccm.200710-1606OC
Gladwin, 2004, Pulmonary hypertension as a risk factor for death in patients with sickle cell disease, N Engl J Med., 350, 886, 10.1056/NEJMoa035477
Ataga, 2006, Pulmonary hypertension in patients with sickle cell disease: A longitudinal study, Br J Haematol., 134, 109, 10.1111/j.1365-2141.2006.06110.x
Machado, 2006, N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease, JAMA., 296, 310, 10.1001/jama.296.3.310
Machado, 2009, NT-pro brain natriuretic peptide levels and the risk of stroke and death in the cooperative study of sickle cell disease, Blood., 114, 1541, 10.1182/blood.V114.22.1541.1541
Klings, 2014, An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease, Am J Respir Crit Care Med., 189, 727, 10.1164/rccm.201401-0065ST
Parent, 2011, A hemodynamic study of pulmonary hypertension in sickle cell disease, N Engl J Med., 365, 44, 10.1056/NEJMoa1005565
Mehari, 2012, Mortality in adults with sickle cell disease and pulmonary hypertension, JAMA., 307, 1254, 10.1001/jama.2012.358
Fonseca, 2012, Pulmonary hypertension diagnosed by right heart catheterization in sickle cell disease, Eur Respir J., 39, 112, 10.1183/09031936.00134410
Machado, 2011, Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity, Blood., 118, 855, 10.1182/blood-2010-09-306167
Anthi, 2007, Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension, Am J Respir Crit Care Med., 175, 1272, 10.1164/rccm.200610-1498OC
Rivera, 2002, Modulation of Gardos channel activity by cytokines in sickle erythrocytes, Blood., 99, 357, 10.1182/blood.V99.1.357
Minniti, 2009, Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease, Br J Haematol., 147, 737, 10.1111/j.1365-2141.2009.07906.x
Machado, 2011, Hospitalization for pain in patients with sickle cell disease treated with sildenafil elevated TRV and low exercise capacity, Blood., 118, 855, 10.1182/blood-2010-09-306167
Machado, 2010, Evaluation of sildenafil therapy for patients with sickle cell disease and increased tricuspid regurgitant velocity: Preliminary results of the walk-PHaSST trial, Am J Respir Crit Care Med, 181, A2514
Grossman, 1975, Wall stress and patterns of hypertrophy in the human left ventricle, J Clin Invest., 56, 56, 10.1172/JCI108079
Gordeuk, 2008, Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency, Am J Hematol, 83, 15, 10.1002/ajh.21016
Sachdev, 2007, Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease, J Am Coll Cardiol., 49, 472, 10.1016/j.jacc.2006.09.038
Dham, 2009, Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease, Am J Cardiol., 104, 713, 10.1016/j.amjcard.2009.04.034
Denenberg, 1983, Cardiac function in sickle cell anemia, Am J Cardiol., 51, 1674, 10.1016/0002-9149(83)90208-4
Lamers, 2006, Evaluation of left ventricular systolic function in pediatric sickle cell anemia patients using the end-systolic wall stress-velocity of circumferential fiber shortening relationship, J Am Coll Cardiol., 47, 2283, 10.1016/j.jacc.2006.03.005
Braga, 2015, Altered left ventricular twist is associated with clinical severity in adults and adolescents with homozygous sickle cell anemia, J Am Soc Echocardiogr, 28, 692, 10.1016/j.echo.2015.01.019
Barbosa, 2014, Assessment of ventricular function in adults with sickle-cell disease: role of two-dimensional speckle-tracking strain, J Am Soc Echocardiogr., 27, 1216, 10.1016/j.echo.2014.07.014
Monte, 2012, Left ventricular rotational dynamics in beta thalassemia major: A speckle-tracking echocardiography study, J Am Soc Echocardiogr., 25, 1083, 10.1016/j.echo.2012.07.007
Di María, 2015, Left ventricular rotational mechanics in Tanzanian children with sickle cell disease, J Am Soc Echocardiogr., 28, 340, 10.1016/j.echo.2014.11.014
